Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

International Stem Cell Comments on Recent SCIENTIFIC AMERICAN Article: “You Say Embryo, I Say Parthenote”

 
“We at International Stem Cell Corporation (OTCQB:ISCO) are finding it increasingly gratifying that mainstream and highly respected publications like Scientific American are now beginning to take notice of the fact that our Parthenogenetic Stem cells may well turn out to be a viable alternative to the embryonic stem cells that have dominated research and headlines for the last 10 years. 
 
 
Like embryonic stem cells, our Parthenogenetic stem cells can be converted into almost any kind of cell that might ever be needed for therapy, but can also provide a solution to the two biggest issues that have surrounded embryonic stem cell research: 1) the ethics of destroying a fertilized embryo, which our process never does, and 2) the problem of immune rejection by the patient.  We hope you enjoy the attached article." 
Ken Aldrich, Founder and Co-Chairman, International Stem Cell Corporation

“You Say Embryo, I Say Parthenote”
Stem cells from unfertilized eggs may be too tightly regulated
By Julia Galef